Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Spectrum Pharma Inc (SPPI)

Spectrum Pharma Inc (SPPI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spectrum Pharma Inc 11500 SOUTH EASTERN AVENUE SUITE 240 HENDERSON NV 89052 USA

P: 702-835-6300 F: 702-260-7405

Description:

Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease.

Key Statistics

Overview:

Market Capitalization, $K 1,073,243
Shares Outstanding, K 112,973
Annual Sales, $ 109,330 K
Annual Net Income, $ -120,010 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -25,990 K
60-Month Beta 2.63
% of Insider Shareholders 9.35%
% of Institutional Shareholders 73.35%
Float, K 102,410
% Float 90.65%

Growth:

1-Year Return -23.00%
3-Year Return 121.62%
5-Year Return 38.59%
5-Year Revenue Growth -29.85%
5-Year Earnings Growth -1,022.22%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.22 on 11/07/19
Next Earnings Date N/A
Earnings Per Share ttm -1.12
EPS Growth vs. Prev Qtr 15.38%
EPS Growth vs. Prev Year -29.41%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 0.150 on 12/18/12
Dividend Payout Ratio 0.00
Most Recent Split 1-25 on 09/06/02

SPPI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -17.52
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -46.70
Return-on-Assets (Before Tax) -35.90
Profit Margin % -109.77
Net Margin % 14.20
Debt/Equity 0.04
Price/Sales 9.79
Price/Cash Flow N/A
Price/Book 4.55
Book Value/Share 2.08
Interest Coverage -351.97
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar